<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9304308</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35129272</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9304308</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1111/ene.15251</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">ENE15251</article-id></all-ids><extracted-table><table-id>ene15251-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>Demographic, clinical, and cognitive information in the matched test sample (age, sex, APOE Ɛ4, and amyloid status matched)</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="ene15251-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Demographic, clinical, and cognitive information in the matched test sample (age, sex, <italic toggle="yes">APOE</italic> Ɛ4, and amyloid status matched)</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Characteristic</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">CN, <italic toggle="yes">n</italic> = 193</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">MCI, <italic toggle="yes">n</italic> = 126</th><th align="left" rowspan="2" valign="bottom" colspan="1"><italic toggle="yes">p</italic><xref rid="ene15251-note-0005" ref-type="table-fn"><sup>c</sup></xref></th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Total, <italic toggle="yes">n</italic> = 193</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>−</sup> participants, <italic toggle="yes">n</italic> = 97</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>+</sup> participants, <italic toggle="yes">n</italic> = 96</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic><xref rid="ene15251-note-0003" ref-type="table-fn"><sup>a</sup></xref></th><th align="left" valign="bottom" rowspan="1" colspan="1">Total, <italic toggle="yes">n</italic> = 126</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>−</sup> participants, <italic toggle="yes">n</italic> = 67</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>+</sup> participants, <italic toggle="yes">n</italic> = 59</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic><xref rid="ene15251-note-0004" ref-type="table-fn"><sup>b</sup></xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, mean (SD), years</td><td align="left" rowspan="1" colspan="1">74.4 (8.2)</td><td align="left" rowspan="1" colspan="1">73.7 (8.5)</td><td align="char" char="(" rowspan="1" colspan="1">75.1 (7.9)</td><td align="left" rowspan="1" colspan="1">0.258</td><td align="left" rowspan="1" colspan="1">74.2 (8.1)</td><td align="left" rowspan="1" colspan="1">74.3 (8.2)</td><td align="char" char="(" rowspan="1" colspan="1">74.2 (8.2)</td><td align="left" rowspan="1" colspan="1">0.938</td><td align="char" char="." rowspan="1" colspan="1">0.866</td></tr><tr><td align="left" rowspan="1" colspan="1">Female, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">119 (61.7)</td><td align="left" rowspan="1" colspan="1">59 (60.8)</td><td align="char" char="(" rowspan="1" colspan="1">60 (62.5)</td><td align="left" rowspan="1" colspan="1">0.883</td><td align="left" rowspan="1" colspan="1">65 (51.6)</td><td align="left" rowspan="1" colspan="1">36 (53.7)</td><td align="char" char="(" rowspan="1" colspan="1">29 (49.2)</td><td align="left" rowspan="1" colspan="1">0.721</td><td align="char" char="." rowspan="1" colspan="1">0.083</td></tr><tr><td align="left" rowspan="1" colspan="1">Education, mean (SD), years</td><td align="left" rowspan="1" colspan="1">16.7 (2.4)</td><td align="left" rowspan="1" colspan="1">17.0 (2.4)</td><td align="char" char="(" rowspan="1" colspan="1">16.4 (2.4)</td><td align="left" rowspan="1" colspan="1">0.092</td><td align="left" rowspan="1" colspan="1">16.5 (2.5)</td><td align="left" rowspan="1" colspan="1">16.8 (2.5)</td><td align="char" char="(" rowspan="1" colspan="1">16.2 (2.4)</td><td align="left" rowspan="1" colspan="1">0.240</td><td align="char" char="." rowspan="1" colspan="1">0.595</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ADAS‐Cog, mean (SD)</bold></td><td align="left" rowspan="1" colspan="1">13.4 (4.9)</td><td align="left" rowspan="1" colspan="1">12.3 (4.1)</td><td align="char" char="(" rowspan="1" colspan="1">14.5 (5.4)</td><td align="left" rowspan="1" colspan="1">0.004<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td><td align="left" rowspan="1" colspan="1">16.2 (5.8)</td><td align="left" rowspan="1" colspan="1">15.8 (5.2)</td><td align="char" char="(" rowspan="1" colspan="1">16.6 (6.3)</td><td align="left" rowspan="1" colspan="1">0.472</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">APOE</italic> Ɛ4 carriers, <italic toggle="yes">n</italic> (%)<xref rid="ene15251-note-0006" ref-type="table-fn"><sup>d</sup></xref></td><td align="left" rowspan="1" colspan="1">35 (27.3)</td><td align="left" rowspan="1" colspan="1">20 (29.4)</td><td align="char" char="(" rowspan="1" colspan="1">15 (25.0)</td><td align="left" rowspan="1" colspan="1">0.692</td><td align="left" rowspan="1" colspan="1">23 (28.0)</td><td align="left" rowspan="1" colspan="1">12 (29.3)</td><td align="char" char="(" rowspan="1" colspan="1">11 (26.8)</td><td align="left" rowspan="1" colspan="1">0.500</td><td align="char" char="." rowspan="1" colspan="1">0.517</td></tr><tr><td align="left" rowspan="1" colspan="1">Amyloid positive, <italic toggle="yes">n</italic> (%)<xref rid="ene15251-note-0007" ref-type="table-fn"><sup>e</sup></xref></td><td align="left" rowspan="1" colspan="1">49 (41.2)</td><td align="left" rowspan="1" colspan="1">27 (43.5)</td><td align="char" char="(" rowspan="1" colspan="1">22 (38.6)</td><td align="left" rowspan="1" colspan="1">0.709</td><td align="left" rowspan="1" colspan="1">28 (43.8)</td><td align="left" rowspan="1" colspan="1">15 (45.5)</td><td align="char" char="(" rowspan="1" colspan="1">13 (41.9)</td><td align="left" rowspan="1" colspan="1">0.806</td><td align="char" char="." rowspan="1" colspan="1">0.756</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Vascular risk, CMC score, mean (SD)</bold></td><td align="left" rowspan="1" colspan="1">1.1 (1.0)</td><td align="left" rowspan="1" colspan="1">0.8 (0.8)</td><td align="char" char="(" rowspan="1" colspan="1">1.4 (1.1)</td><td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td><td align="left" rowspan="1" colspan="1">1.3 (0.9)</td><td align="left" rowspan="1" colspan="1">1.2 (0.9)</td><td align="char" char="(" rowspan="1" colspan="1">1.4 (0.9)</td><td align="left" rowspan="1" colspan="1">0.279</td><td align="char" char="." rowspan="1" colspan="1">0.102</td></tr><tr><td align="left" rowspan="1" colspan="1">Total ACB score, median (range)</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td><td align="char" char="(" rowspan="1" colspan="1">1 (1–7)</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td><td align="char" char="(" rowspan="1" colspan="1">1 (1–7)</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Psychiatric</bold></td><td align="left" rowspan="1" colspan="1">54 (28.0)</td><td align="left" rowspan="1" colspan="1">21 (21.6)</td><td align="char" char="(" rowspan="1" colspan="1">33 (34.4)</td><td align="left" rowspan="1" colspan="1">0.055</td><td align="left" rowspan="1" colspan="1">50 (39.7)</td><td align="left" rowspan="1" colspan="1">22 (32.8)</td><td align="char" char="(" rowspan="1" colspan="1">28 (47.5)</td><td align="left" rowspan="1" colspan="1">0.104</td><td align="char" char="." rowspan="1" colspan="1">0.038<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Neurologic, other than cognitive disorder</bold></td><td align="left" rowspan="1" colspan="1">74 (38.3)</td><td align="left" rowspan="1" colspan="1">27 (27.8)</td><td align="char" char="(" rowspan="1" colspan="1">47 (49.0)</td><td align="left" rowspan="1" colspan="1">0.003<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td><td align="left" rowspan="1" colspan="1">69 (54.8)</td><td align="left" rowspan="1" colspan="1">32 (47.8)</td><td align="char" char="(" rowspan="1" colspan="1">37 (62.7)</td><td align="left" rowspan="1" colspan="1">0.108</td><td align="char" char="." rowspan="1" colspan="1">0.006<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Head, eyes, ears, nose, throat</td><td align="left" rowspan="1" colspan="1">130 (67.4)</td><td align="left" rowspan="1" colspan="1">60 (61.9)</td><td align="char" char="(" rowspan="1" colspan="1">70 (72.9)</td><td align="left" rowspan="1" colspan="1">0.125</td><td align="left" rowspan="1" colspan="1">84 (66.7)</td><td align="left" rowspan="1" colspan="1">44 (65.7)</td><td align="char" char="(" rowspan="1" colspan="1">40 (67.8)</td><td align="left" rowspan="1" colspan="1">0.851</td><td align="char" char="." rowspan="1" colspan="1">0.904</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Cardiovascular</bold></td><td align="left" rowspan="1" colspan="1">133 (68.9)</td><td align="left" rowspan="1" colspan="1">55 (56.7)</td><td align="char" char="(" rowspan="1" colspan="1">78 (81.3)</td><td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td><td align="left" rowspan="1" colspan="1">94 (74.6)</td><td align="left" rowspan="1" colspan="1">46 (68.7)</td><td align="char" char="(" rowspan="1" colspan="1">48 (81.4)</td><td align="left" rowspan="1" colspan="1">0.151</td><td align="char" char="." rowspan="1" colspan="1">0.312</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Respiratory</bold></td><td align="left" rowspan="1" colspan="1">47 (24.4)</td><td align="left" rowspan="1" colspan="1">17 (17.5)</td><td align="char" char="(" rowspan="1" colspan="1">30 (31.3)</td><td align="left" rowspan="1" colspan="1">0.030<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td><td align="left" rowspan="1" colspan="1">42 (33.3)</td><td align="left" rowspan="1" colspan="1">16 (23.9)</td><td align="char" char="(" rowspan="1" colspan="1">26 (44.1)</td><td align="left" rowspan="1" colspan="1">0.023<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td><td align="char" char="." rowspan="1" colspan="1">0.097</td></tr><tr><td align="left" rowspan="1" colspan="1">Hepatic</td><td align="left" rowspan="1" colspan="1">6 (3.1)</td><td align="left" rowspan="1" colspan="1">3 (3.1)</td><td align="char" char="(" rowspan="1" colspan="1">3 (3.1)</td><td align="left" rowspan="1" colspan="1">0.654</td><td align="left" rowspan="1" colspan="1">5 (4.0)</td><td align="left" rowspan="1" colspan="1">2 (3.0)</td><td align="char" char="(" rowspan="1" colspan="1">3 (5.1)</td><td align="left" rowspan="1" colspan="1">0.664</td><td align="char" char="." rowspan="1" colspan="1">0.758</td></tr><tr><td align="left" rowspan="1" colspan="1">Dermatologic connective tissue</td><td align="left" rowspan="1" colspan="1">73 (37.8)</td><td align="left" rowspan="1" colspan="1">37 (38.1)</td><td align="char" char="(" rowspan="1" colspan="1">36 (37.5)</td><td align="left" rowspan="1" colspan="1">0.522</td><td align="left" rowspan="1" colspan="1">43 (34.1)</td><td align="left" rowspan="1" colspan="1">24 (35.8)</td><td align="char" char="(" rowspan="1" colspan="1">19 (32.2)</td><td align="left" rowspan="1" colspan="1">0.710</td><td align="char" char="." rowspan="1" colspan="1">0.552</td></tr><tr><td align="left" rowspan="1" colspan="1">Musculoskeletal</td><td align="left" rowspan="1" colspan="1">151 (78.2)</td><td align="left" rowspan="1" colspan="1">73 (75.3)</td><td align="char" char="(" rowspan="1" colspan="1">78 (81.3)</td><td align="left" rowspan="1" colspan="1">0.384</td><td align="left" rowspan="1" colspan="1">94 (74.6)</td><td align="left" rowspan="1" colspan="1">49 (73.1)</td><td align="char" char="(" rowspan="1" colspan="1">45 (76.3)</td><td align="left" rowspan="1" colspan="1">0.838</td><td align="char" char="." rowspan="1" colspan="1">0.498</td></tr><tr><td align="left" rowspan="1" colspan="1">Endocrine–metabolic</td><td align="left" rowspan="1" colspan="1">105 (54.4)</td><td align="left" rowspan="1" colspan="1">51 (52.6)</td><td align="char" char="(" rowspan="1" colspan="1">54 (56.3)</td><td align="left" rowspan="1" colspan="1">0.665</td><td align="left" rowspan="1" colspan="1">76 (60.3)</td><td align="left" rowspan="1" colspan="1">39 (58.2)</td><td align="char" char="(" rowspan="1" colspan="1">37 (62.7)</td><td align="left" rowspan="1" colspan="1">0.716</td><td align="char" char="." rowspan="1" colspan="1">0.355</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Gastrointestinal</bold></td><td align="left" rowspan="1" colspan="1">109 (56.5)</td><td align="left" rowspan="1" colspan="1">47 (48.5)</td><td align="char" char="(" rowspan="1" colspan="1">62 (64.6)</td><td align="left" rowspan="1" colspan="1">0.029<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td><td align="left" rowspan="1" colspan="1">69 (54.8)</td><td align="left" rowspan="1" colspan="1">32 (47.8)</td><td align="char" char="(" rowspan="1" colspan="1">37 (62.7)</td><td align="left" rowspan="1" colspan="1">0.108</td><td align="char" char="." rowspan="1" colspan="1">0.818</td></tr><tr><td align="left" rowspan="1" colspan="1">Hematopoietic–lymphatic</td><td align="left" rowspan="1" colspan="1">22 (11.4)</td><td align="left" rowspan="1" colspan="1">13 (13.4)</td><td align="char" char="(" rowspan="1" colspan="1">9 (9.4)</td><td align="left" rowspan="1" colspan="1">0.498</td><td align="left" rowspan="1" colspan="1">17 (13.5)</td><td align="left" rowspan="1" colspan="1">11 (16.4)</td><td align="char" char="(" rowspan="1" colspan="1">6 (10.2)</td><td align="left" rowspan="1" colspan="1">0.434</td><td align="char" char="." rowspan="1" colspan="1">0.603</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal–genitourinary</td><td align="left" rowspan="1" colspan="1">101 (52.3)</td><td align="left" rowspan="1" colspan="1">50 (51.5)</td><td align="char" char="(" rowspan="1" colspan="1">51 (53.1)</td><td align="left" rowspan="1" colspan="1">0.886</td><td align="left" rowspan="1" colspan="1">56 (44.4)</td><td align="left" rowspan="1" colspan="1">30 (44.8)</td><td align="char" char="(" rowspan="1" colspan="1">26 (44.1)</td><td align="left" rowspan="1" colspan="1">0.540</td><td align="char" char="." rowspan="1" colspan="1">0.172</td></tr><tr><td align="left" rowspan="1" colspan="1">Allergies or drug sensitivities</td><td align="left" rowspan="1" colspan="1">75 (38.9)</td><td align="left" rowspan="1" colspan="1">32 (33.0)</td><td align="char" char="(" rowspan="1" colspan="1">43 (44.8)</td><td align="left" rowspan="1" colspan="1">0.105</td><td align="left" rowspan="1" colspan="1">48 (38.1)</td><td align="left" rowspan="1" colspan="1">23 (34.3)</td><td align="char" char="(" rowspan="1" colspan="1">25 (42.4)</td><td align="left" rowspan="1" colspan="1">0.365</td><td align="char" char="." rowspan="1" colspan="1">0.907</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking, alcohol use, and/or drug use</td><td align="left" rowspan="1" colspan="1">17 (8.8)</td><td align="left" rowspan="1" colspan="1">5 (5.2)</td><td align="char" char="(" rowspan="1" colspan="1">12 (12.5)</td><td align="left" rowspan="1" colspan="1">0.081</td><td align="left" rowspan="1" colspan="1">20 (15.9)</td><td align="left" rowspan="1" colspan="1">7 (10.4)</td><td align="char" char="(" rowspan="1" colspan="1">13 (22.0)</td><td align="left" rowspan="1" colspan="1">0.091</td><td align="char" char="." rowspan="1" colspan="1">0.073</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Malignancy</bold></td><td align="left" rowspan="1" colspan="1">44 (22.8)</td><td align="left" rowspan="1" colspan="1">18 (18.6)</td><td align="char" char="(" rowspan="1" colspan="1">26 (27.1)</td><td align="left" rowspan="1" colspan="1">0.173</td><td align="left" rowspan="1" colspan="1">14 (11.1)</td><td align="left" rowspan="1" colspan="1">8 (11.9)</td><td align="char" char="(" rowspan="1" colspan="1">6 (10.2)</td><td align="left" rowspan="1" colspan="1">0.785</td><td align="char" char="." rowspan="1" colspan="1">0.008<xref rid="ene15251-note-0008" ref-type="table-fn">*</xref></td></tr></tbody></table><table-wrap-foot id="ene15251-ntgp-0002"><fn id="ene15251-note-0002"><p>Abbreviations: AC, anticholinergic; ACB, AC burden; ADAS‐Cog, Alzheimer's Disease Assessment Scale–Cognitive Subscale; CMC, chronic metabolic conditions; CN, cognitively normal; MCI, mild cognitive impairment. Dominant characteristics are shown in bold.</p></fn><fn id="ene15251-note-0003"><p><bold><sup>a</sup>P value of:</bold> group comparison using <italic toggle="yes">t</italic>‐test between CN and MCI participants.</p></fn><fn id="ene15251-note-0004"><p><bold><sup>b</sup>P value of:</bold> group comparison using <italic toggle="yes">t</italic>‐test between AC<sup>−</sup> CN and AC<sup>+</sup> CN participants.</p></fn><fn id="ene15251-note-0005"><p><bold><sup>c</sup>P value of:</bold> group comparison using <italic toggle="yes">t</italic>‐test between AC<sup>−</sup> MCI and AC<sup>+</sup> MCI participants.</p></fn><fn id="ene15251-note-0006"><label>d</label><p>In total, 210 participants had <italic toggle="yes">APOE</italic> Ɛ4 carrier information.</p></fn><fn id="ene15251-note-0007"><label>e</label><p>In total, 183 participants had amyloid information.</p></fn><fn id="ene15251-note-0008"><label>*</label><p>Significant at <italic toggle="yes">p</italic> &lt; 0.05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic, clinical, and cognitive information in the matched test sample (age, sex, APOE Ɛ4, and amyloid status matched)</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom">Characteristic</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom">CN, n = 193</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom">MCI, n = 126</th><th align="left" rowspan="2" valign="bottom">p???</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">Total, n = 193</th><th align="left" valign="bottom">AC− participants, n = 97</th><th align="left" valign="bottom">AC+ participants, n = 96</th><th align="left" valign="bottom">p???</th><th align="left" valign="bottom">Total, n = 126</th><th align="left" valign="bottom">AC− participants, n = 67</th><th align="left" valign="bottom">AC+ participants, n = 59</th><th align="left" valign="bottom">p???</th></tr></thead><tbody><tr><td align="left">Age, mean (SD), years</td><td align="left">74.4 (8.2)</td><td align="left">73.7 (8.5)</td><td align="char" char="(">75.1 (7.9)</td><td align="left">0.258</td><td align="left">74.2 (8.1)</td><td align="left">74.3 (8.2)</td><td align="char" char="(">74.2 (8.2)</td><td align="left">0.938</td><td align="char" char=".">0.866</td></tr><tr><td align="left">Female, n (%)</td><td align="left">119 (61.7)</td><td align="left">59 (60.8)</td><td align="char" char="(">60 (62.5)</td><td align="left">0.883</td><td align="left">65 (51.6)</td><td align="left">36 (53.7)</td><td align="char" char="(">29 (49.2)</td><td align="left">0.721</td><td align="char" char=".">0.083</td></tr><tr><td align="left">Education, mean (SD), years</td><td align="left">16.7 (2.4)</td><td align="left">17.0 (2.4)</td><td align="char" char="(">16.4 (2.4)</td><td align="left">0.092</td><td align="left">16.5 (2.5)</td><td align="left">16.8 (2.5)</td><td align="char" char="(">16.2 (2.4)</td><td align="left">0.240</td><td align="char" char=".">0.595</td></tr><tr><td align="left">ADAS‐Cog, mean (SD)</td><td align="left">13.4 (4.9)</td><td align="left">12.3 (4.1)</td><td align="char" char="(">14.5 (5.4)</td><td align="left">0.004???</td><td align="left">16.2 (5.8)</td><td align="left">15.8 (5.2)</td><td align="char" char="(">16.6 (6.3)</td><td align="left">0.472</td><td align="char" char=".">&lt;0.001???</td></tr><tr><td align="left">APOE Ɛ4 carriers, n (%)???</td><td align="left">35 (27.3)</td><td align="left">20 (29.4)</td><td align="char" char="(">15 (25.0)</td><td align="left">0.692</td><td align="left">23 (28.0)</td><td align="left">12 (29.3)</td><td align="char" char="(">11 (26.8)</td><td align="left">0.500</td><td align="char" char=".">0.517</td></tr><tr><td align="left">Amyloid positive, n (%)???</td><td align="left">49 (41.2)</td><td align="left">27 (43.5)</td><td align="char" char="(">22 (38.6)</td><td align="left">0.709</td><td align="left">28 (43.8)</td><td align="left">15 (45.5)</td><td align="char" char="(">13 (41.9)</td><td align="left">0.806</td><td align="char" char=".">0.756</td></tr><tr><td align="left">Vascular risk, CMC score, mean (SD)</td><td align="left">1.1 (1.0)</td><td align="left">0.8 (0.8)</td><td align="char" char="(">1.4 (1.1)</td><td align="left">&lt;0.001???</td><td align="left">1.3 (0.9)</td><td align="left">1.2 (0.9)</td><td align="char" char="(">1.4 (0.9)</td><td align="left">0.279</td><td align="char" char=".">0.102</td></tr><tr><td align="left">Total ACB score, median (range)</td><td align="left">–</td><td align="left">–</td><td align="char" char="(">1 (1–7)</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="char" char="(">1 (1–7)</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">Psychiatric</td><td align="left">54 (28.0)</td><td align="left">21 (21.6)</td><td align="char" char="(">33 (34.4)</td><td align="left">0.055</td><td align="left">50 (39.7)</td><td align="left">22 (32.8)</td><td align="char" char="(">28 (47.5)</td><td align="left">0.104</td><td align="char" char=".">0.038???</td></tr><tr><td align="left">Neurologic, other than cognitive disorder</td><td align="left">74 (38.3)</td><td align="left">27 (27.8)</td><td align="char" char="(">47 (49.0)</td><td align="left">0.003???</td><td align="left">69 (54.8)</td><td align="left">32 (47.8)</td><td align="char" char="(">37 (62.7)</td><td align="left">0.108</td><td align="char" char=".">0.006???</td></tr><tr><td align="left">Head, eyes, ears, nose, throat</td><td align="left">130 (67.4)</td><td align="left">60 (61.9)</td><td align="char" char="(">70 (72.9)</td><td align="left">0.125</td><td align="left">84 (66.7)</td><td align="left">44 (65.7)</td><td align="char" char="(">40 (67.8)</td><td align="left">0.851</td><td align="char" char=".">0.904</td></tr><tr><td align="left">Cardiovascular</td><td align="left">133 (68.9)</td><td align="left">55 (56.7)</td><td align="char" char="(">78 (81.3)</td><td align="left">&lt;0.001???</td><td align="left">94 (74.6)</td><td align="left">46 (68.7)</td><td align="char" char="(">48 (81.4)</td><td align="left">0.151</td><td align="char" char=".">0.312</td></tr><tr><td align="left">Respiratory</td><td align="left">47 (24.4)</td><td align="left">17 (17.5)</td><td align="char" char="(">30 (31.3)</td><td align="left">0.030???</td><td align="left">42 (33.3)</td><td align="left">16 (23.9)</td><td align="char" char="(">26 (44.1)</td><td align="left">0.023???</td><td align="char" char=".">0.097</td></tr><tr><td align="left">Hepatic</td><td align="left">6 (3.1)</td><td align="left">3 (3.1)</td><td align="char" char="(">3 (3.1)</td><td align="left">0.654</td><td align="left">5 (4.0)</td><td align="left">2 (3.0)</td><td align="char" char="(">3 (5.1)</td><td align="left">0.664</td><td align="char" char=".">0.758</td></tr><tr><td align="left">Dermatologic connective tissue</td><td align="left">73 (37.8)</td><td align="left">37 (38.1)</td><td align="char" char="(">36 (37.5)</td><td align="left">0.522</td><td align="left">43 (34.1)</td><td align="left">24 (35.8)</td><td align="char" char="(">19 (32.2)</td><td align="left">0.710</td><td align="char" char=".">0.552</td></tr><tr><td align="left">Musculoskeletal</td><td align="left">151 (78.2)</td><td align="left">73 (75.3)</td><td align="char" char="(">78 (81.3)</td><td align="left">0.384</td><td align="left">94 (74.6)</td><td align="left">49 (73.1)</td><td align="char" char="(">45 (76.3)</td><td align="left">0.838</td><td align="char" char=".">0.498</td></tr><tr><td align="left">Endocrine–metabolic</td><td align="left">105 (54.4)</td><td align="left">51 (52.6)</td><td align="char" char="(">54 (56.3)</td><td align="left">0.665</td><td align="left">76 (60.3)</td><td align="left">39 (58.2)</td><td align="char" char="(">37 (62.7)</td><td align="left">0.716</td><td align="char" char=".">0.355</td></tr><tr><td align="left">Gastrointestinal</td><td align="left">109 (56.5)</td><td align="left">47 (48.5)</td><td align="char" char="(">62 (64.6)</td><td align="left">0.029???</td><td align="left">69 (54.8)</td><td align="left">32 (47.8)</td><td align="char" char="(">37 (62.7)</td><td align="left">0.108</td><td align="char" char=".">0.818</td></tr><tr><td align="left">Hematopoietic–lymphatic</td><td align="left">22 (11.4)</td><td align="left">13 (13.4)</td><td align="char" char="(">9 (9.4)</td><td align="left">0.498</td><td align="left">17 (13.5)</td><td align="left">11 (16.4)</td><td align="char" char="(">6 (10.2)</td><td align="left">0.434</td><td align="char" char=".">0.603</td></tr><tr><td align="left">Renal–genitourinary</td><td align="left">101 (52.3)</td><td align="left">50 (51.5)</td><td align="char" char="(">51 (53.1)</td><td align="left">0.886</td><td align="left">56 (44.4)</td><td align="left">30 (44.8)</td><td align="char" char="(">26 (44.1)</td><td align="left">0.540</td><td align="char" char=".">0.172</td></tr><tr><td align="left">Allergies or drug sensitivities</td><td align="left">75 (38.9)</td><td align="left">32 (33.0)</td><td align="char" char="(">43 (44.8)</td><td align="left">0.105</td><td align="left">48 (38.1)</td><td align="left">23 (34.3)</td><td align="char" char="(">25 (42.4)</td><td align="left">0.365</td><td align="char" char=".">0.907</td></tr><tr><td align="left">Smoking, alcohol use, and/or drug use</td><td align="left">17 (8.8)</td><td align="left">5 (5.2)</td><td align="char" char="(">12 (12.5)</td><td align="left">0.081</td><td align="left">20 (15.9)</td><td align="left">7 (10.4)</td><td align="char" char="(">13 (22.0)</td><td align="left">0.091</td><td align="char" char=".">0.073</td></tr><tr><td align="left">Malignancy</td><td align="left">44 (22.8)</td><td align="left">18 (18.6)</td><td align="char" char="(">26 (27.1)</td><td align="left">0.173</td><td align="left">14 (11.1)</td><td align="left">8 (11.9)</td><td align="char" char="(">6 (10.2)</td><td align="left">0.785</td><td align="char" char=".">0.008???</td></tr></tbody></table></div>Abbreviations: AC, anticholinergic; ACB, AC burden; ADAS‐Cog, Alzheimer's Disease Assessment Scale–Cognitive Subscale; CMC, chronic metabolic conditions; CN, cognitively normal; MCI, mild cognitive impairment. Dominant characteristics are shown in bold.aP value of: group comparison using t‐test between CN and MCI participants.bP value of: group comparison using t‐test between AC− CN and AC+ CN participants.cP value of: group comparison using t‐test between AC− MCI and AC+ MCI participants.dIn total, 210 participants had APOE Ɛ4 carrier information.eIn total, 183 participants had amyloid information.*Significant at p &lt; 0.05.John Wiley &amp; Sons, Ltd</transformed-table></extracted-table><extracted-table><table-id>ene15251-tbl-0002</table-id><table-label>TABLE 2</table-label><table-caption>Structural and functional measurements of imaging markers</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="ene15251-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Structural and functional measurements of imaging markers</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Measurement</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Cognitively normal</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">MCI</th><th align="left" rowspan="2" valign="bottom" colspan="1"><italic toggle="yes">p</italic></th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Total, <italic toggle="yes">n</italic> = 193</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>−</sup> participants, <italic toggle="yes">n</italic> = 97</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>+</sup> participants, <italic toggle="yes">n</italic> = 96</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic></th><th align="left" valign="bottom" rowspan="1" colspan="1">Total, <italic toggle="yes">n</italic> = 126</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>−</sup> participants, <italic toggle="yes">n</italic> = 67</th><th align="left" valign="bottom" rowspan="1" colspan="1">AC<sup>+</sup> participants, <italic toggle="yes">n</italic> = 59</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">NBM GM density, mean voxel value (SD)<xref rid="ene15251-note-0010" ref-type="table-fn"><sup>a</sup></xref></td><td align="char" char="(" rowspan="1" colspan="1">0.57 (0.04)</td><td align="char" char="(" rowspan="1" colspan="1">0.57 (0.05)</td><td align="char" char="(" rowspan="1" colspan="1">0.57 (0.03)</td><td align="char" char="." rowspan="1" colspan="1">0.824</td><td align="char" char="(" rowspan="1" colspan="1">0.56 (0.03)</td><td align="char" char="(" rowspan="1" colspan="1">0.56 (0.03)</td><td align="char" char="(" rowspan="1" colspan="1">0.55 (0.03)</td><td align="char" char="." rowspan="1" colspan="1">0.002<xref rid="ene15251-note-0012" ref-type="table-fn">*</xref></td><td align="char" char="." rowspan="1" colspan="1">0.010<xref rid="ene15251-note-0012" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">NBM‐NBM network functional connectivity, mean (SD), <italic toggle="yes">Z</italic> score<xref rid="ene15251-note-0011" ref-type="table-fn"><sup>b</sup></xref></td><td align="char" char="(" rowspan="1" colspan="1">3.7 (0.5)</td><td align="char" char="(" rowspan="1" colspan="1">3.9 (0.6)</td><td align="char" char="(" rowspan="1" colspan="1">3.6 (0.5)</td><td align="char" char="." rowspan="1" colspan="1">0.001<xref rid="ene15251-note-0012" ref-type="table-fn">*</xref></td><td align="char" char="(" rowspan="1" colspan="1">3.48 (0.4)</td><td align="char" char="(" rowspan="1" colspan="1">3.66 (0.46)</td><td align="char" char="(" rowspan="1" colspan="1">3.29 (0.20)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001<xref rid="ene15251-note-0012" ref-type="table-fn">*</xref></td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001<xref rid="ene15251-note-0012" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Visual cortex functional connectivity, mean (SD), <italic toggle="yes">Z</italic> score<xref rid="ene15251-note-0011" ref-type="table-fn"><sup>b</sup></xref></td><td align="char" char="(" rowspan="1" colspan="1">5.1 (0.8)</td><td align="char" char="(" rowspan="1" colspan="1">4.9 (0.8)</td><td align="char" char="(" rowspan="1" colspan="1">5.1 (0.8)</td><td align="char" char="." rowspan="1" colspan="1">0.254</td><td align="char" char="(" rowspan="1" colspan="1">4.9 (0.8)</td><td align="char" char="(" rowspan="1" colspan="1">4.8 (0.8)</td><td align="char" char="(" rowspan="1" colspan="1">5.0 (0.8)</td><td align="char" char="." rowspan="1" colspan="1">0.388</td><td align="char" char="." rowspan="1" colspan="1">0.188</td></tr><tr><td align="left" rowspan="1" colspan="1">Whole hippocampal GM volume, mean (SD), cm<sup>3</sup></td><td align="char" char="(" rowspan="1" colspan="1">7.31 (0.88)</td><td align="char" char="(" rowspan="1" colspan="1">7.44 (0.80)</td><td align="char" char="(" rowspan="1" colspan="1">7.16 (0.95)</td><td align="char" char="." rowspan="1" colspan="1">0.119</td><td align="char" char="(" rowspan="1" colspan="1">7.17 (0.90)</td><td align="char" char="(" rowspan="1" colspan="1">7.20 (0.86)</td><td align="char" char="(" rowspan="1" colspan="1">7.14 (0.96)</td><td align="char" char="." rowspan="1" colspan="1">0.581</td><td align="char" char="." rowspan="1" colspan="1">0.153</td></tr><tr><td align="left" rowspan="1" colspan="1">Whole precuneus GM volume, mean (SD), cm<sup>3</sup></td><td align="char" char="(" rowspan="1" colspan="1">17.05 (2.43)</td><td align="char" char="(" rowspan="1" colspan="1">17.11 (2.45)</td><td align="char" char="(" rowspan="1" colspan="1">16.98 (2.41)</td><td align="char" char="." rowspan="1" colspan="1">0.999</td><td align="char" char="(" rowspan="1" colspan="1">17.54 (2.16)</td><td align="char" char="(" rowspan="1" colspan="1">17.6 (2.2)</td><td align="char" char="(" rowspan="1" colspan="1">17.5 (2.1)</td><td align="char" char="." rowspan="1" colspan="1">0.864</td><td align="char" char="." rowspan="1" colspan="1">0.095</td></tr></tbody></table><table-wrap-foot id="ene15251-ntgp-0003"><fn id="ene15251-note-0009"><p>Abbreviations: AC, anticholinergic; ANOVA, analysis of variance; GM, gray matter; MCI, mild cognitive impairment; NBM, nucleus basalis of Meynert.</p></fn><fn id="ene15251-note-0010"><label>a</label><p>Group comparison using ANOVA test controlled for age.</p></fn><fn id="ene15251-note-0011"><label>b</label><p>Group comparison using ANOVA test controlled for age and education.</p></fn><fn id="ene15251-note-0012"><label>*</label><p>Significant level at <italic toggle="yes">p</italic> &lt; 0.05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Structural and functional measurements of imaging markers</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><col style="border-right:solid 1px #000000"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom">Measurement</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom">Cognitively normal</th><th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom">MCI</th><th align="left" rowspan="2" valign="bottom">p</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">Total, n = 193</th><th align="left" valign="bottom">AC− participants, n = 97</th><th align="left" valign="bottom">AC+ participants, n = 96</th><th align="left" valign="bottom">p</th><th align="left" valign="bottom">Total, n = 126</th><th align="left" valign="bottom">AC− participants, n = 67</th><th align="left" valign="bottom">AC+ participants, n = 59</th><th align="left" valign="bottom">p</th></tr></thead><tbody><tr><td align="left">NBM GM density, mean voxel value (SD)???</td><td align="char" char="(">0.57 (0.04)</td><td align="char" char="(">0.57 (0.05)</td><td align="char" char="(">0.57 (0.03)</td><td align="char" char=".">0.824</td><td align="char" char="(">0.56 (0.03)</td><td align="char" char="(">0.56 (0.03)</td><td align="char" char="(">0.55 (0.03)</td><td align="char" char=".">0.002???</td><td align="char" char=".">0.010???</td></tr><tr><td align="left">NBM‐NBM network functional connectivity, mean (SD), Z score???</td><td align="char" char="(">3.7 (0.5)</td><td align="char" char="(">3.9 (0.6)</td><td align="char" char="(">3.6 (0.5)</td><td align="char" char=".">0.001???</td><td align="char" char="(">3.48 (0.4)</td><td align="char" char="(">3.66 (0.46)</td><td align="char" char="(">3.29 (0.20)</td><td align="char" char=".">&lt;0.001???</td><td align="char" char=".">&lt;0.001???</td></tr><tr><td align="left">Visual cortex functional connectivity, mean (SD), Z score???</td><td align="char" char="(">5.1 (0.8)</td><td align="char" char="(">4.9 (0.8)</td><td align="char" char="(">5.1 (0.8)</td><td align="char" char=".">0.254</td><td align="char" char="(">4.9 (0.8)</td><td align="char" char="(">4.8 (0.8)</td><td align="char" char="(">5.0 (0.8)</td><td align="char" char=".">0.388</td><td align="char" char=".">0.188</td></tr><tr><td align="left">Whole hippocampal GM volume, mean (SD), cm3</td><td align="char" char="(">7.31 (0.88)</td><td align="char" char="(">7.44 (0.80)</td><td align="char" char="(">7.16 (0.95)</td><td align="char" char=".">0.119</td><td align="char" char="(">7.17 (0.90)</td><td align="char" char="(">7.20 (0.86)</td><td align="char" char="(">7.14 (0.96)</td><td align="char" char=".">0.581</td><td align="char" char=".">0.153</td></tr><tr><td align="left">Whole precuneus GM volume, mean (SD), cm3</td><td align="char" char="(">17.05 (2.43)</td><td align="char" char="(">17.11 (2.45)</td><td align="char" char="(">16.98 (2.41)</td><td align="char" char=".">0.999</td><td align="char" char="(">17.54 (2.16)</td><td align="char" char="(">17.6 (2.2)</td><td align="char" char="(">17.5 (2.1)</td><td align="char" char=".">0.864</td><td align="char" char=".">0.095</td></tr></tbody></table></div>Abbreviations: AC, anticholinergic; ANOVA, analysis of variance; GM, gray matter; MCI, mild cognitive impairment; NBM, nucleus basalis of Meynert.aGroup comparison using ANOVA test controlled for age.bGroup comparison using ANOVA test controlled for age and education.*Significant level at p &lt; 0.05.John Wiley &amp; Sons, Ltd</transformed-table></extracted-table></extracted-tables-set>